Copyright © 2001 by the European Society of Cardiology.
Editorials
Refractory heart failuredrugs and devices
Chatterjee Center for Cardiac Research, University of California, San Francisco, California, U.S.A.
Key Words: Published online 6 September 2001
References
- De Marco T, Chatterjee K, Rouleau J. Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J. 1988;115:809[CrossRef][ISI][Medline]
- Garg R, Yusuf S. Overview of randomized trials of angiotensin converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273:14501601
[Abstract/Free Full Text] - Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:13491355
[Abstract/Free Full Text] - Lancet. 1999;353:913[CrossRef][ISI][Medline]
- Lancet. 1999;353:20012007[CrossRef][ISI][Medline]
- Brophy JM, Joseph L, Rouleau JL. B-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med. 2001;134:550560
[Abstract/Free Full Text] - Packer M, Coats AJS, Fowler MB. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:16511658
[Abstract/Free Full Text] - Cohn JN, Archibald DG, Ziesche S. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a veterans administration cooperative Study. N Engl J Med. 1988;314:15471552
- Cohn JN, Johnson G, Ziesche S. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303310[Abstract]
- Pitt B, Zannad F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709717
[Abstract/Free Full Text] - Am Heart Assoc. 1999;:129
- De Marco T, Chatterjee K. Phosphodiesterase inhibitors in refractory heart failure: bridge to beta-blockade. J Am Coll Cardiol. 1998;31:13411343
[Free Full Text] - Loebe M, Hennig E, Müller J. Long-term mechanical circulatory support as a bridge to transplantation for recovery from cardiomyopathy and for permanent replacement. Eur J Cardiothorac Surg. 1997;11:1824
- Clark AL, Loebe M, Potapov E. Ventricular assist device in severe heart failure. Effects on cytokines, complement and body weight. Eur Heart J. 2001;22:22752283
[Abstract/Free Full Text] - Mancini DM, Beniaminovitz Levin H. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chonic heart failure. Circulation. 1998;98:23832389
[Abstract/Free Full Text] - Rosenthal N. High hopes for the heart (editorial). N Engl J Med. 2001;344:17851787
[Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||